- Supported exchanges /
- F /
- 1S1.F
VIRIDIAN THERAPEUTICS (1S1 F) stock market data APIs
Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
VIRIDIAN THERAPEUTICS Financial Data Overview
21.2 | |
21.2 | |
- | |
21.2 | |
21.2 | |
10.2-21.6 | |
1 669 M | |
76 356 K | |
288 K | |
-2.21 | |
1.091 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
VIRIDIAN THERAPEUTICS Fundamental Data is available in our Financial Data APIs
- Net Revenue 288 K
- EBITDA -250 212 992
- Earnings Per Share -3.9
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get VIRIDIAN THERAPEUTICS Earnings via APIs
- Latest Release 2021-06-30
- EPS/Forecast -1.52
Get VIRIDIAN THERAPEUTICS End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: